Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
Journal of Medicinal Chemistry
|
June 12, 2019
Application of Dually Activated Michael Acceptor to the Rational Design of Reversible Covalent Inhibitor for Enterovirus 71 3C Protease
Yuying Ma, Linfeng Li, Shuai He, et al.
ACS Chemical Biology
|
March 10, 2021
Covalent Inactivation of <i>Mycobacterium tuberculosis</i> Isocitrate Lyase by <i>cis</i>-2,3-Epoxy-Succinic Acid
Truc Viet Pham, Drake M Mellott, Zahra Moghadamchargari, et al.
Chemical Communications (Cambridge, England)
|
August 2, 2021
Dinitrosyl iron complexes (DNICs) as inhibitors of the SARS-CoV-2 main protease
D Chase Pectol, Christopher R DeLaney, Jiyun Zhu, et al.
Analytical Chemistry
|
September 25, 2024
Insights into the Main Protease of SARS-CoV-2: Thermodynamic Analysis, Structural Characterization, and the Impact of Inhibitors
Jamie P Butalewicz, Sarah N Sipe, Kyle J Juetten, et al.
Journal of the American Chemical Society
|
October 19, 2021
Mechanism-Based Inactivation of <i>Mycobacterium tuberculosis</i> Isocitrate Lyase 1 by (2<i>R</i>,3<i>S</i>)-2-Hydroxy-3-(nitromethyl)succinic acid
Drake M Mellott, Dan Torres, Inna V Krieger, et al.
Biochemistry
|
August 30, 2012
The amino-acid substituents of dipeptide substrates of cathepsin C can determine the rate-limiting steps of catalysis
Jon K Rubach, Guanglei Cui, Jessica L Schneck, et al.
Biochemistry
|
June 5, 2012
On the catalytic mechanism of human ATP citrate lyase
Fan Fan, Howard J Williams, Joseph G Boyer, et al.
Journal of Medicinal Chemistry
|
April 21, 2026
Peptidomimetic α,β-Unsaturated Ethyl Esters Are Irreversible Inactivators of Human Cathepsin L and Are Potent Inhibitors of SARS-CoV-2 in Cellular Models of COVID-19
Vivek Kumar, Aleksandra Drelich, Bala C Chenna, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 7, 2017
Mechanism-based inactivator of isocitrate lyases 1 and 2 from <i>Mycobacterium tuberculosis</i>
Truc V Pham, Andrew S Murkin, Margaret M Moynihan, et al.
Biochemistry
|
October 4, 2022
Kinetic Characterization and Inhibition of <i>Trypanosoma cruzi</i> Hypoxanthine-Guanine Phosphoribosyltransferases
Kayla Glockzin, Demetrios Kostomiris, Yacoba V T Minnow, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
Journal of Medicinal Chemistry
|
June 12, 2019
Application of Dually Activated Michael Acceptor to the Rational Design of Reversible Covalent Inhibitor for Enterovirus 71 3C Protease
Yuying Ma, Linfeng Li, Shuai He, et al.
ACS Chemical Biology
|
March 10, 2021
Covalent Inactivation of <i>Mycobacterium tuberculosis</i> Isocitrate Lyase by <i>cis</i>-2,3-Epoxy-Succinic Acid
Truc Viet Pham, Drake M Mellott, Zahra Moghadamchargari, et al.
Chemical Communications (Cambridge, England)
|
August 2, 2021
Dinitrosyl iron complexes (DNICs) as inhibitors of the SARS-CoV-2 main protease
D Chase Pectol, Christopher R DeLaney, Jiyun Zhu, et al.
Analytical Chemistry
|
September 25, 2024
Insights into the Main Protease of SARS-CoV-2: Thermodynamic Analysis, Structural Characterization, and the Impact of Inhibitors
Jamie P Butalewicz, Sarah N Sipe, Kyle J Juetten, et al.
Journal of the American Chemical Society
|
October 19, 2021
Mechanism-Based Inactivation of <i>Mycobacterium tuberculosis</i> Isocitrate Lyase 1 by (2<i>R</i>,3<i>S</i>)-2-Hydroxy-3-(nitromethyl)succinic acid
Drake M Mellott, Dan Torres, Inna V Krieger, et al.
Biochemistry
|
August 30, 2012
The amino-acid substituents of dipeptide substrates of cathepsin C can determine the rate-limiting steps of catalysis
Jon K Rubach, Guanglei Cui, Jessica L Schneck, et al.
Biochemistry
|
June 5, 2012
On the catalytic mechanism of human ATP citrate lyase
Fan Fan, Howard J Williams, Joseph G Boyer, et al.
Journal of Medicinal Chemistry
|
April 21, 2026
Peptidomimetic α,β-Unsaturated Ethyl Esters Are Irreversible Inactivators of Human Cathepsin L and Are Potent Inhibitors of SARS-CoV-2 in Cellular Models of COVID-19
Vivek Kumar, Aleksandra Drelich, Bala C Chenna, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 7, 2017
Mechanism-based inactivator of isocitrate lyases 1 and 2 from <i>Mycobacterium tuberculosis</i>
Truc V Pham, Andrew S Murkin, Margaret M Moynihan, et al.
Biochemistry
|
October 4, 2022
Kinetic Characterization and Inhibition of <i>Trypanosoma cruzi</i> Hypoxanthine-Guanine Phosphoribosyltransferases
Kayla Glockzin, Demetrios Kostomiris, Yacoba V T Minnow, et al.
Page
of 4